# reload+after+2024-01-22 03:33:32.833548
address1§2825 Airview Boulevard
city§Kalamazoo
state§MI
zip§49002
country§United States
phone§269 385 2600
fax§269 385 1062
website§https://www.stryker.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
fullTimeEmployees§51000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Kevin A. Lobo', 'age': 58, 'title': 'Chairman, CEO & President', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 3308170, 'exercisedValue': 33137196, 'unexercisedValue': 123261336}, {'maxAge': 1, 'name': 'Mr. Glenn S. Boehnlein', 'age': 61, 'title': 'VP & CFO', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1426201, 'exercisedValue': 0, 'unexercisedValue': 23230860}, {'maxAge': 1, 'name': 'Mr. Viju S. Menon', 'age': 55, 'title': 'Group President of Global Quality & Operations', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 1045846, 'exercisedValue': 0, 'unexercisedValue': 4343974}, {'maxAge': 1, 'name': 'Mr. J. Andrew Pierce', 'age': 49, 'title': 'Group President of MedSurg & Neurotechnology', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 1315797, 'exercisedValue': 0, 'unexercisedValue': 10780912}, {'maxAge': 1, 'name': 'Mr. Spencer S. Stiles', 'age': 46, 'title': 'Group President of Orthopaedics & Spine', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 1284794, 'exercisedValue': 2130602, 'unexercisedValue': 8779723}, {'maxAge': 1, 'name': 'Mr. William E. Berry Jr.', 'age': 57, 'title': 'VP & Chief Accounting Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robert C. Cohen', 'title': 'CTO and VP of Global R&D - Joint Replacement', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alan  Douville', 'title': 'VP, Chief Information Officer & Chief Information Security Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason  Beach', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robert S. Fletcher', 'age': 52, 'title': 'VP & Chief Legal Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 895895, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§5
compensationRisk§5
shareHolderRightsRisk§6
overallRisk§6
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§3.2
dividendYield§0.0108
exDividendDate§1703721600
payoutRatio§0.44509998
fiveYearAvgDividendYield§1.06
beta§0.926
priceToSalesTrailing12Months§5.6428
currency§USD
dateShortInterest§1702598400
forwardEps§11.55
pegRatio§2.7
exchange§NYQ
quoteType§EQUITY
shortName§Stryker Corporation
longName§Stryker Corporation
firstTradeDateEpochUtc§322151400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b9837935-4aa5-32a4-a908-5a60748ac1d1
gmtOffSetMilliseconds§-18000000
targetHighPrice§355.0
targetLowPrice§297.0
targetMeanPrice§324.35
targetMedianPrice§322.0
recommendationMean§2.1
recommendationKey§buy
numberOfAnalystOpinions§23
quickRatio§0.699
earningsGrowth§-0.159
grossMargins§0.63606
ebitdaMargins§0.25109
trailingPegRatio§2.8668
